Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.05
Delayed Data
As of Feb 11
 -0.17 / -2.73%
Today’s Change
5.50
Today|||52-Week Range
11.40
-19.76%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.22
Today’s open6.00
Day’s range5.80 - 6.30
Volume22,783
Average volume (3 months)9,355
Market cap$26.0M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)-250.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+26.46%
P/E ratio17.9
Price/Sales1.94
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
CLSNCelsion Corp-0.02-1.82%
XTNTXtant Medical Holdin...+0.06+2.62%
BINDBIND Therapeutics In...+0.06+5.08%
BNTCBenitec Biopharma Lt...-0.19-5.19%
Data as of 02/11/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$7.6M
Annual profit (last year)-$167.2K
Net profit margin-2.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Partner Offers